Metoprolol succinate NDC 51655-919

Product information

Brand name (proprietary)

Metoprolol succinate

Generic name (nonproprietary)

metoprolol succinate

Active ingredients

Metoprolol succinate — 50 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Northwind Health Company, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 213854

Marketing start

Apr 20, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 51655-919_49742b7b-65bb-49da-e063-6394a90a353aSPL ID 49742b7b-65bb-49da-e063-6394a90a353aSPL set ID fa16cb4e-d70a-d07f-e053-6294a90a9512RxCUI 866436UNII TH25PD4CCB

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655091926 followed by a unit qualifier and the quantity Copy

Package 51655-0919-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 213854

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.